Business Services Industry

Bergen Brunswig And Ivax Granted Early Termination Of Waiting Period By Federal Trade Commission

Business Wire, Dec 12, 1996

ORANGE, Calif.--(BUSINESS WIRE)--Dec. 12, 1996--Bergen Brunswig Corporation (NYSE:BBC) and IVAX Corporation (AMEX:IVX) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Act with respect to the pending merger of Bergen Brunswig Corporation and IVAX Corporation.

Consummation of the merger remains subject to the effectiveness of a registration statement and to shareholder approval.

Bergen Brunswig Corporation, headquartered in Orange, California, provides nationwide distribution of pharmaceuticals and medical-surgical supplies to chain and independent pharmacies, hospitals, HMOs, nursing homes, clinics and physician groups.

IVAX Corporation, headquartered in Miami, Florida, is a holding company with subsidiaries engaged in the research, development, manufacture and marketing of health care products, including generic and branded pharmaceuticals, intravenous solutions and related products, and in vitro diagnostics.

CONTACT: Bergen Brunswig Corp., Orange

Lisa Riordan (investors)

800/840-5131

or

IVAX Corp., Miami

Joseph C. Jones (communications)

800/980-IVAX

COPYRIGHT 1996 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale